GILEAD SCIENCES, INC. Fair Value, Measurement with Unobservable Inputs Reconciliation, Recurring Basis, Liability, Issuances
GILEAD SCIENCES, INC. (GILD) reported Fair Value, Measurement with Unobservable Inputs Reconciliation, Recurring Basis, Liability, Issuances of $0 for the 6-month period ending 2014-06-30, per its 10-Q filed 2014-08-04.
Discontinued › Notes › Fair Value Measures and Disclosures › Fair Value Disclosures › Fair Value, Assets and Liabilities Measured on Recurring Basis, Unobservable Input Reconciliation › Fair Value, Measurement with Unobservable Inputs Reconciliation, Recurring Basis, Liability, Purchases, (Sales), Issuances, (Settlements)
us-gaap:FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilityIssues · last filed 2014-08-04
- GILEAD SCIENCES, INC. fair value, measurement with unobservable inputs reconciliation, recurring basis, liability, issuances for the quarter ending 2014-06-30 was $0.00.
- GILEAD SCIENCES, INC. fair value, measurement with unobservable inputs reconciliation, recurring basis, liability, issuances for the quarter ending 2014-03-31 was $0.00.
- GILEAD SCIENCES, INC. fair value, measurement with unobservable inputs reconciliation, recurring basis, liability, issuances for the quarter ending 2013-12-31 was $0.00.
- GILEAD SCIENCES, INC. fair value, measurement with unobservable inputs reconciliation, recurring basis, liability, issuances for the quarter ending 2013-09-30 was $0.00.
- GILEAD SCIENCES, INC. fair value, measurement with unobservable inputs reconciliation, recurring basis, liability, issuances for fiscal 2013 was $0.00.
- GILEAD SCIENCES, INC. fair value, measurement with unobservable inputs reconciliation, recurring basis, liability, issuances for fiscal 2012 was $0.00, a 100.00% decline from fiscal 2011.
- GILEAD SCIENCES, INC. fair value, measurement with unobservable inputs reconciliation, recurring basis, liability, issuances for fiscal 2011 was $116.01M.
| Period end | Fair Value, Measurement with Unobservable Inputs Reconciliation, Recurring Basis, Liability, Issuances 3 month | Fair Value, Measurement with Unobservable Inputs Reconciliation, Recurring Basis, Liability, Issuances 6 month | Fair Value, Measurement with Unobservable Inputs Reconciliation, Recurring Basis, Liability, Issuances 9 month | Fair Value, Measurement with Unobservable Inputs Reconciliation, Recurring Basis, Liability, Issuances 12 month |
|---|---|---|---|---|
| 2014-06-30 | $0.00 derived: 10-Q 6 month − 10-Q 3 month · filed 2014-08-04 | $0.00 10-Q · filed 2014-08-04 | $0.00 derived: sum of 3 quarters · filed 2014-08-04 | $0.00 derived: sum of 4 quarters · filed 2014-08-04 |
| 2014-03-31 | $0.00 10-Q · filed 2014-05-07 | $0.00 derived: sum of 2 quarters · filed 2014-05-07 | $0.00 derived: sum of 3 quarters · filed 2014-05-07 | $0.00 derived: sum of 4 quarters · filed 2014-05-07 |
| 2013-12-31 | $0.00 derived: 10-K 12 month − 10-Q 9 month · filed 2014-02-25 | $0.00 derived: sum of 2 quarters · filed 2014-02-25 | $0.00 derived: sum of 3 quarters · filed 2014-02-25 | $0.00 10-K · filed 2014-02-25 |
| 2013-09-30 | $0.00 derived: 10-Q 9 month − 10-Q 6 month · filed 2013-10-31 | $0.00 derived: sum of 2 quarters · filed 2013-10-31 | $0.00 10-Q · filed 2013-10-31 | $0.00 derived: sum of 4 quarters · filed 2014-02-25 |
| 2013-06-30 | $0.00 derived: 10-Q 6 month − 10-Q 3 month · filed 2013-08-01 | $0.00 10-Q · filed 2013-08-01 | $0.00 derived: sum of 3 quarters · filed 2014-02-25 | $0.00 derived: sum of 4 quarters · filed 2014-02-25 |
| 2013-03-31 | $0.00 10-Q · filed 2013-05-08 | $0.00 derived: sum of 2 quarters · filed 2014-02-25 | $0.00 derived: sum of 3 quarters · filed 2014-02-25 | |
| 2012-12-31 | $0.00 derived: 10-K 12 month − 10-Q 9 month · filed 2014-02-25 | $0.00 derived: sum of 2 quarters · filed 2014-02-25 | $0.00 10-K · filed 2014-02-25 | |
| 2012-09-30 | $0.00 10-Q · filed 2012-11-06 | $0.00 10-Q · filed 2012-11-06 | ||
| 2011-12-31 | $0.00 derived: 10-K 12 month − 10-Q 9 month · filed 2013-02-27 | $0.00 derived: sum of 2 quarters · filed 2013-02-27 | $116.01M 10-K · filed 2013-02-27 | |
| 2011-09-30 | $0.00 10-Q · filed 2012-11-06 | $116.01M 10-Q · filed 2012-11-06 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| AMGEN INC (AMGN) | United States | $219.567B | 22.39 |
| Moderna, Inc. (MRNA) | United States | $77.819B | -8.86 |
| Revolution Medicines, Inc. (RVMD) | United States | $42.805B | -22.69 |
| BIOGEN INC. (BIIB) | United States | $33.427B | 19.60 |
| EXELIXIS, INC. (EXEL) | United States | $14.358B | 16.15 |
| NEUROCRINE BIOSCIENCES INC (NBIX) | United States | $14.131B | 24.25 |
| HALOZYME THERAPEUTICS, INC. (HALO) | United States | $13.083B | 21.59 |
| Twist Bioscience Corp (TWST) | United States | $11.540B | -47.21 |
| BIO-TECHNE Corp (TECH) | United States | $11.379B | 74.68 |
| REPLIGEN CORP (RGEN) | United States | $10.755B | 185.31 |